Published in J Clin Invest on February 01, 1984
Paracetamol and metabolite pharmacokinetics in infants. Eur J Clin Pharmacol (2003) 1.65
Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm Res (2013) 1.62
Acetaminophen liver injury. Can Fam Physician (1985) 0.91
Inhibition of the metabolism of paracetamol by isoniazid. Br J Clin Pharmacol (1991) 0.84
Paracetamol-induced hepatotoxicity: lack of enhancement of the hepatoprotective effect of N-acetylcysteine by sodium sulphate. Inflammopharmacology (1998) 0.76
The effect of propranolol on paracetamol metabolism in man. Br J Clin Pharmacol (1990) 0.75
Comparing the Therapeutic Effectiveness of N-acetylcysteine with the Combination of N-acetyl Cysteine and Cimetidine in Acute Acetaminophen Toxicity: A Double-Blinded Clinical Trial. Electron Physician (2015) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem (1969) 15.62
Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther (1973) 4.40
Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet (1971) 4.40
Successful treatment of severe paracetamol overdosage with cysteamine. Lancet (1974) 3.83
Delayed clearance of diazepam due to cimetidine. N Engl J Med (1980) 3.45
Oral methionine in the treatment of severe paracetamol (Acetaminophen) overdose. Lancet (1976) 3.20
Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet (1977) 3.00
Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clin Pharmacol Ther (1974) 2.62
A kinetic study of drug elimination: the excretion of paracetamol and its metabolites in man. Br J Pharmacol Chemother (1967) 1.99
Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen. Pharmacology (1974) 1.70
Cimetidine impairs elimination of chlordiazepoxide (Librium) in man. Ann Intern Med (1980) 1.61
Interaction of cimetidine with liver microsomes. Xenobiotica (1979) 1.45
Acetaminophen toxicity in human lymphocytes in vitro. J Pharmacol Exp Ther (1980) 1.34
Cimetidine spares the glucuronidation of lorazepam and oxazepam. Gastroenterology (1980) 1.33
Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo. J Clin Invest (1983) 1.31
Inhibition of microsomal drug metabolism by histamine H2-receptor antagonists studied in vivo and in vitro in rodents. Gastroenterology (1982) 1.27
Evidence that acetaminophen and N-hydroxyacetaminophen form a common arylating intermediate, N-acetyl-p-benzoquinoneimine. Mol Pharmacol (1980) 1.18
Drug metabolism by rat and human hepatic microsomes in response to interaction with H2-receptor antagonists. Gastroenterology (1982) 1.15
Effects of oral contraceptive steroids on acetaminophen metabolism and elimination. Clin Pharmacol Ther (1983) 1.07
Acetaminophen kinetics in acutely poisoned patients. Clin Pharmacol Ther (1979) 1.03
Effect of cimetidine and other antihistaminics on the elimination of aminopyrine, phenacetin and caffeine. Life Sci (1980) 1.00
Differential effect of cimetidine on drug oxidation (antipyrine and diazepam) vs. conjugation (acetaminophen and lorazepam): prevention of acetaminophen toxicity by cimetidine. J Pharmacol Exp Ther (1983) 0.97
On the inhibitory action of mersalyl on microsomal drug oxidation: a rigid organization of the electron transport chain. Arch Biochem Biophys (1971) 0.96
Lack of tolerance and rapid recovery of cimetidine-inhibited chlordiazepoxide (Librium) elimination. Gastroenterology (1981) 0.90
Cimetidine protects against acetaminophen hepatotoxicity in rats. Gastroenterology (1981) 0.85
Renal excretion of cimetidine. J Pharmacol Exp Ther (1981) 0.81
Direct protection against acetaminophen hepatotoxicity by propylthiouracil. In vivo and in vitro studies in rats and mice. J Clin Invest (1981) 0.80
Paracetamol-induced hepatic necrosis in the mouse-relationship between covalent binding, hepatic glutathione depletion and the protective effect of alpha-mercaptopropionylglycine. Biochem Pharmacol (1977) 0.80
The curative effects of cysteamine, cysteine, and dithiocarb in experimental paracetamol poisoning. Arch Toxicol (1974) 0.79
Prevention of acetaminophen-induced hepatic necrosis by cimetidine in mice. Res Commun Chem Pathol Pharmacol (1981) 0.77
Metyrapone as a treatment for acetaminophen (paracetamol) toxicity in mice. Res Commun Chem Pathol Pharmacol (1979) 0.77
The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J Clin Invest (1975) 4.65
Budd-Chiari syndrome: etiology, diagnosis and management. Medicine (Baltimore) (1982) 1.92
Fulminant hepatic failure after ingestion of sustained-release nicotinic acid. Ann Intern Med (1989) 1.74
Normal disposition of oxazepam in acute viral hepatitis and cirrhosis. Ann Intern Med (1976) 1.68
Cimetidine impairs elimination of chlordiazepoxide (Librium) in man. Ann Intern Med (1980) 1.61
Acute hepatic necrosis with stupor or coma. An analysis of thirty-one patients. Medicine (Baltimore) (1969) 1.55
Amylase--its clinical significance: a review of the literature. Medicine (Baltimore) (1976) 1.51
The liver in congestive heart failure: a review. Am J Med Sci (1973) 1.50
Effect of age and parenchymal liver disease on the disposition and elimination of chlordiazepoxide (librium). Gastroenterology (1978) 1.48
Acyclovir transport by the human placenta. J Lab Clin Med (1992) 1.42
Phosphotyrosyl-protein phosphatase of TCRC-2 cells. J Biol Chem (1982) 1.41
Impaired elimination of caffeine by oral contraceptive steroids. J Lab Clin Med (1980) 1.41
Effects of aging and liver disease on disposition of lorazepam. Clin Pharmacol Ther (1978) 1.39
Cimetidine spares the glucuronidation of lorazepam and oxazepam. Gastroenterology (1980) 1.33
Fatty liver: biochemical and clinical considerations. Am J Dig Dis (1975) 1.30
Studies on the intracerebral toxicity of ammonia. J Clin Invest (1967) 1.27
Pathogenesis of hepatic encephalopathy--with special reference to the role of ammonia. Am J Clin Nutr (1970) 1.27
Inhibition of microsomal drug metabolism by histamine H2-receptor antagonists studied in vivo and in vitro in rodents. Gastroenterology (1982) 1.27
Mephenytoin hydroxylation deficiency: kinetics after repeated doses. Clin Pharmacol Ther (1984) 1.25
Normal metabolism of morphine in cirrhosis. Gastroenterology (1981) 1.22
The effect of cirrhosis on the disposition and elimination of meperidine in man. Clin Pharmacol Ther (1974) 1.22
A prospective study to determine the efficacy of antibiotics in acute pancreatitis. Ann Surg (1976) 1.20
In utero ethanol exposure causes mitochondrial dysfunction, which can result in apoptotic cell death in fetal brain: a potential role for 4-hydroxynonenal. Alcohol Clin Exp Res (2001) 1.18
Disposition of chlordiazepoxide: sex differences and effects of oral contraceptives. Clin Pharmacol Ther (1979) 1.16
Drug disposition and liver disease. Drug Metab Rev (1975) 1.14
Bacteremia with upper gastrointestinal endoscopy. Ann Intern Med (1975) 1.13
Hepatic encephalopathy. Gastroenterology (1979) 1.13
Disposition of aminopyrine, antipyrine, diazepam, and indocyanine green in patients with liver disease or on anticonvulsant drug therapy: diazepam breath test and correlations in drug elimination. J Lab Clin Med (1977) 1.13
The risk of alcohol intake in men and women: all may not be equal. N Engl J Med (1990) 1.11
Effects of liver disease on drug disposition in man. Biochem Pharmacol (1976) 1.11
Hepatic encephalopathy: current status. Gastroenterology (1974) 1.10
Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res (1990) 1.10
Lack of effect of nizatidine on hepatic drug metabolism in man. Br J Clin Pharmacol (1985) 1.09
Effects of oral contraceptive steroids on acetaminophen metabolism and elimination. Clin Pharmacol Ther (1983) 1.07
Absence of circulating interferon in patients with infectious and serum hepatitis. Proc Soc Exp Biol Med (1968) 1.07
Catalase mediates acetaldehyde formation from ethanol in fetal and neonatal rat brain. Alcohol Clin Exp Res (1997) 1.07
Endoscopic biliary stent migration with small bowel perforation in a liver transplant recipient. J Clin Gastroenterol (1997) 1.06
Alcohol-induced impairment of central nervous system function: behavioral skills involved in driving. J Stud Alcohol Suppl (1985) 1.05
Intrahepatic cholestasis due to therapy of rheumatoid arthritis. Gastroenterology (1973) 1.04
Inhibition of cytochrome c oxidase activity by 4-hydroxynonenal (HNE). Role of HNE adduct formation with the enzyme subunits. Biochim Biophys Acta (1998) 1.04
Effect of ketoconazole on hepatic oxidative drug metabolism. Clin Pharmacol Ther (1985) 1.03
Ethanol, oxidative stress, reactive aldehydes, and the fetus. Front Biosci (1999) 1.03
Nature of the urinary concentrating defect in the Gunn strain of rat. Am J Physiol (1969) 1.02
Alcohol and dietary intake in the development of chronic pancreatitis and liver disease in alcoholism. Am J Clin Nutr (1988) 1.02
Major drug interactions: effect of liver disease, alcohol, and malnutrition. Annu Rev Med (1982) 1.01
Pioglitazone in the treatment of NASH: the role of adiponectin. Aliment Pharmacol Ther (2010) 1.01
Encephalopathy of thiamine deficieny: studies of intracerebral mechanisms. J Clin Invest (1968) 1.01
Stereoselective metabolism of mephenytoin in man. J Pharmacol Exp Ther (1981) 1.00
Medical treatment vs. transplantation in liver disorders. Hepatology (1984) 1.00
Urease: a sensitive and specific radiometric assay. Enzymologia (1972) 1.00
Effect of cimetidine and other antihistaminics on the elimination of aminopyrine, phenacetin and caffeine. Life Sci (1980) 1.00
Insignificant transfer of glyburide occurs across the human placenta. Am J Obstet Gynecol (1991) 0.99
Formation of 4-hydroxynonenal adducts with cytochrome c oxidase in rats following short-term ethanol intake. Hepatology (1999) 0.98
Obstructive jaundice and gastrointestinal hemorrhage in progressive systemic sclerosis. Arch Intern Med (1968) 0.98
Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer. Am J Obstet Gynecol (1994) 0.98
Isolation of function human trophoblast cells and their partial characterization in primary cell culture. In Vitro (1978) 0.98
Cimetidine and procainamide secretion by proximal tubules in vitro. Am J Physiol (1982) 0.97
Is glucuronidation truly preserved in patients with liver disease? Hepatology (1991) 0.97
Granulomatous hepatitis associated with carbamazepine therapy. Am J Med (1981) 0.96
Plasma binding of benzodiazepines in humans. J Pharm Sci (1979) 0.95
Formation of malondialdehyde adducts in livers of rats exposed to ethanol: role in ethanol-mediated inhibition of cytochrome c oxidase. Alcohol Clin Exp Res (2000) 0.95
Effect of acute hypoxia on hepatic excretory function. Am J Physiol (1969) 0.95
Stereoselective metabolism and disposition of the enantiomers of mephenytoin during chronic oral administration of the racemic drug in man. J Pharmacol Exp Ther (1982) 0.94
The effect of ketoconazole on hepatic oxidative drug metabolism in the rat in vivo and in vitro. Drug Metab Dispos (1985) 0.94
Thiamine transport across the rat intestine. I. Normal characteristics. Gastroenterology (1975) 0.94
Effect of aspirin on prostaglandin E2 formation and transforming growth factor alpha expression in human rectal mucosa from individuals with a history of adenomatous polyps of the colon. Cancer Epidemiol Biomarkers Prev (1999) 0.92
Abnormal regulation of plasma pyridoxal 5'-phosphate in patients with liver disease. Gastroenterology (1976) 0.92
Characteristics of alkaline phosphatase from two continuous lines of human choriocarcinoma cells. Exp Cell Res (1977) 0.92
Neomycin absorption in man. Studies of oral and enema administration and effect of intestinal ulceration. Ann Intern Med (1972) 0.91
Effect of heparin administration on plasma binding of benzodiazepines. Br J Clin Pharmacol (1980) 0.91
Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial. Hepatology (1984) 0.91
The disposition and effects of sedatives and analgesics in liver disease. Annu Rev Med (1978) 0.90
Effects of chronic ethanol feeding on glutathione turnover in the rat. Biochem Pharmacol (1985) 0.90
Lack of tolerance and rapid recovery of cimetidine-inhibited chlordiazepoxide (Librium) elimination. Gastroenterology (1981) 0.90
Thiamine transport across the rat intestine. II. Effect of ethanol. J Lab Clin Med (1975) 0.90
4-hydroxynonenal levels are enhanced in fetal liver mitochondria by in utero ethanol exposure. Hepatology (1997) 0.89
Clearance and metabolism of plasma pyridoxal 5'-phosphate in the dog. J Lab Clin Med (1984) 0.88
Plasma long chain fatty acids and esterified lipids in cirrhosis and hepatic encephalopathy. Am J Med Sci (1979) 0.88
The stimulation by methotrexate of human chorionic gonadotropin and placental alkaline phosphatase in cultured choriocarcinoma cells. Cancer Res (1976) 0.88
Transport and metabolism of thiamin in isolated rat hepatocytes. J Biol Chem (1979) 0.88
In utero ethanol exposure elicits oxidative stress in the rat fetus. Alcohol Clin Exp Res (1995) 0.88
Maternal-to-fetal transfer of 5-methyltetrahydrofolate by the perfused human placental cotyledon: evidence for a concentrative role by placental folate receptors in fetal folate delivery. J Lab Clin Med (1995) 0.88
Role of prostacyclin in the splanchnic hyperemia contributing to portal hypertension. Ann Surg (1989) 0.88
Physostigmine reversal of diazepam-induced hypnosis. A study in human volunteers. Ann Intern Med (1979) 0.88
Role of hepatic adenosine triphosphate in BSP transport and metabolism in vivo. Am J Physiol (1967) 0.87
Effects of influenza virus vaccine on hepatic drug metabolism. Clin Pharmacol Ther (1985) 0.87
Pancreatic phlegmon. Clinical features and course. Dig Dis Sci (1985) 0.87
Cerebral energy metabolism in short-chain fatty acid-induced coma. J Lab Clin Med (1970) 0.87
Effect of vegetable and animal protein diets in chronic hepatic encephalopathy. Am J Dig Dis (1977) 0.87
Characterization of steroid production in cultured human choriocarcinoma cells. J Clin Endocrinol Metab (1981) 0.87